The Global Market for Infusion Pumps is Projected to Reach US$13.4 Billion by 2022

Aging Population & Globalization of Unhealthy Lifestyles and the Resulting Rise in Chronic Disease Burden to Drive the Infusion Pumps Market, According to a New Report by Global Industry Analysts, Inc.

GIA launches comprehensive analysis of industry segments, trends, growth drivers, market share, size and demand forecasts on the global Infusion Pumps market. The global market for Infusion Pumps is projected to reach US$13.4 billion by 2022, driven by factors such as rising disease burden; popularity of infusion therapy for treating diseases unresponsive to oral antibiotics such as cancer, Crohn's disease, hemophilia, immune deficiencies, multiple sclerosis, congestive heart failure, chronic pain, rheumatoid arthritis etc; innovation in smart infusion pumps and migration towards alternate settings for the delivery of infusion therapy.

An infusion pump is a device designed to enable easy administration of nutrients and medications such as insulin, pain relievers, antibiotics, and chemotherapy drugs in accordance with patient requirements. While certain pumps are intended for stationary use, others are suitable for ambulatory applications. The growth in the market is driven by factors such as increasing incidence of chronic diseases, and the ever-present need for safer and advanced infusion technologies. The recent years witnessed some of the major breakthrough developments in bringing interoperability, connectivity and integration into infusion pump systems. Latest advancements and extensive R&D associated with infusion systems and accessories have led to the availability of next-generation smart pumps capable of providing therapeutic treatments for a number of medical conditions. Apart from delivering the dose in a controlled, precise manner, these pumps enable enhanced patient compliance and reduce overall operational costs. Technologies poised to exert strong growth include remotely operated wireless pumps (with dose-calculation and error reduction software (DERS) and drug libraries, Computerized prescriber order entry (CPOE), and Bar-Coded Medication Administration (BCMA) to ensure accurate medication to the concerned patient, among others.

Insulin infusion pumps segment is poised to record the fastest growth largely driven by cutting edge innovations, such as smart insulin pumps incorporated with glucose monitors and meters and easy to apply pump sets. These innovations have in effect simplified and improved the operations, thereby enhancing patient’s care and safety, thus resulting in higher demand. Ambulatory infusion pumps represent another high growth segment. Enteral feeding, also known as artificial nutritional support systems, is perceived as the most preferred treatment option for patients with gastrointestinal tract disorders. Overall adoption of these devices is also supported by technological advancements that have resulted in reliable and safe products capable of avoiding complications including tube dislodgement, misconnections, tube blockage and aspiration. The infusion technology offers an attractive option for parenteral administration of desirable drug formulations for pain management.

As stated by the new market research report on Infusion pumps, the United States represents the largest market worldwide. Asia-Pacific ranks as the fastest growing market with a CAGR of 8.7% over the analysis period, led by factors such as growing population and strong relationship between economic growth, upwardly mobile lifestyles and rise in chronic disease burden; developing healthcare infrastructure and improving accessibility to next-generation healthcare solutions and services; and growing popularity of home or alternate site infusion therapy as a result of high treatment cost in hospital settings and overcrowded and overstretched hospital resources.  

Major players covered in the report include Animas Corporation, Baxter International Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Fresenius SE & Co. KGaA, Halyard Health Inc., Hospira Inc., ICU Medical Inc., Insulet Corporation, Medtronic Plc, Moog Inc., Smiths Medical, Sooil Development Co. Ltd., Tandem Diabetes Care Inc., Teleflex Incorporated, and Terumo Corporation, among others.

The research report titled “Infusion Pumps: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities of global companies. The report provides market estimates and projections for all major geographic markets such as the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia and Rest of Europe) Asia-Pacific (China, India and Rest of Asia-Pacific), Latin America (Brazil and Rest of Latin America) and Rest of World. The report analyses the global and regional markets by the following Product Segments - Ambulatory Infusion Pumps, Enteral Feeding Pumps, Insulin Infusion Pumps, Large Volume Infusion Pumps, PCA Infusion Pumps, and Syringe Infusion Pumps.

Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.